LIFE: aTyr Pharma, Inc. Stock

by  •  • Comments Off on LIFE: aTyr Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 108.03
Enterprise Value ($M) 85.29
Book Value ($M) 90.47
Book Value / Share 1.33
Price / Book 1.19
NCAV ($M) 72.81
NCAV / Share 1.07
Price / NCAV 1.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.48
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.46

Liquidity (mrq)
Quick Ratio 6.27
Current Ratio 6.27

Balance Sheet (mrq) ($M)
Current Assets 102.99
Assets 120.65
Liabilities 30.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.35
Operating Income -54.92
Net Income -50.39
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.22
Cash from Investing -20.13
Cash from Financing 66.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Lytton Laurence W 1.00 -86.82
02-13 13G/A Stonepine Capital Management, LLC 0.80 -89.83
02-09 13G/A Fmr Llc 15.00 101.87
01-18 13G/A Federated Hermes, Inc. 17.37 94.39
01-02 13G Logos Global Management LP 9.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 42,965 394,388 10.89
2024-05-01 50,087 615,251 8.14
2024-04-30 47,600 219,225 21.71
2024-04-29 33,230 75,644 43.93

(click for more detail)

Similar Companies
LEXX – Lexaria Bioscience Corp. LFVN – LifeVantage Corporation
LGVN – Longeveron Inc. LIPO – Lipella Pharmaceuticals Inc.
LIXT – Lixte Biotechnology Holdings, Inc.


Financial data and stock pages provided by
Fintel.io